Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Wall Street Divided On Buying The IBM Dip

IBM

IBM (NYSE: IBM) dropped more than 7 percent Wednesday after the company released a disappointing Q3 earnings report.

Wall Street analysts are mixed on whether or not the sell-off is a buying opportunity for long-term investors. Here’s a sampling of what some analysts had to say about IBM.

Voices From The Street

Wells Fargo analyst Ed Caso said improvements in Services is encouraging, but deceleration in Cognitive is a potential red flag.

“The decline in Cognitive drove a deceleration in total cc growth for strategic imperatives (7% yr/yr in Q3 vs. 13% in Q2) and remains a concern, in our view,” Caso wrote.

Bank of America analyst Wamsi Mohan said Wednesday’s sell-off presents a particularly attractive entry point for investors.

“We view the stock favorably, given services improvement, and attractive div yield of 4.6%,” Mohan wrote.

Morgan Stanley analyst Katy Huberty said Q4 will be critical for IBM.

“Mgmt was surprisingly bullish on the 4Q deal pipeline but investors are likely to take a wait and see approach,” Huberty wrote.

Guggenheim analyst Robert Cihra said the primary concern for IBM investors is that revenue appears to be shifting rather than growing.

“We see the biggest negative being another downtick in Cognitive Solutions Software (revs -5%Y/Y ex-currency even worse than our -3%Y/Y estimate), which IBM is guiding to rebound Y/Y in 4QE, but we think ‘should’ be its strongest not weakest business given big acquisitions, Watson, Analytics and Security,” Cihra wrote.

Ratings And Price Targets

  • Wells Fargo has a Market Perform rating and $155 target.
  • Bank of America has a Buy rating and $200 target.
  • Morgan Stanley has an Overweight rating and $168 target.
  • Guggenheim has a Neutral rating and no target.

At time of publication, IBM shares were trading down 6.1 percent to $136.26.

Related Links:

IBM Platforms CTO On Collaboration Between Banks, Fintech Startups: 'There's No Shortage Of Desire On Either Side'

Q2 13F Roundup: How Buffett, Einhorn, Loeb And Others Adjusted Their Portfolio

Photo credit: Patrick, Flick

Latest Ratings for IBM

Date Firm Action From To
Oct 2018 Cantor Fitzgerald Maintains Neutral Neutral
Oct 2018 BMO Capital Maintains Market Perform Market Perform
Oct 2018 Moffett Nathanson Initiates Coverage On Sell

View More Analyst Ratings for IBM
View the Latest Analyst Ratings



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today